InspireMD IncNASDAQ:NSPR
- LAST PRICE2.4600
- TODAY'S CHANGE (%)-0.0100 (-0.4049%)
- Bid / Lots2.4500/ 1
- Ask / Lots2.4900/ 2
- Open / Previous Close2.4750 / 2.4700
- Day Range
- 52 Week Range
- Volume3,058
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NSPR |
|---|---|---|
| 10:27 ET | 504 | 2.475 |
| 10:33 ET | 700 | 2.49 |
| 10:36 ET | 375 | 2.535 |
| 11:18 ET | 240 | 2.4541 |
| 11:32 ET | 810 | 2.46 |
Yesterday
InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones
8:00AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 15, 2024
*DJ InspireMD: Establishing Global Headquarters in Miami, Florida, from 7:01AM ET on Tuesday Oct 15, 2024 by Dow Jones
7:01AM ET on Tuesday Oct 15, 2024 by Dow JonesInspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System, from 7:00AM ET on Tuesday Oct 15, 2024 by Dow Jones
7:00AM ET on Tuesday Oct 15, 2024 by Dow Jones
Oct 7, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
InspireMD Inc | 63.5M | -3.3x | --- |
Nutriband Inc | 64.5M | -7.0x | --- |
Medinotec Inc | 58.7M | -2,688.2x | --- |
Vivani Medical Inc | 69.6M | -2.7x | --- |
Baird Medical Investment Holdings Ltd | 71.4M | -3.9x | --- |
Monogram Technologies Inc | 72.9M | -6.1x | --- |
Company Information
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Contact Information
- Headquarters
- 4 Menorat Hamaor St.TEL AVIV-YAFO, Israel 6744832
- Phone
- 857-453-6553
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Paul Stuka
- President, Chief Executive Officer, Director
- Marvin Slosman
- Chief Financial Officer, Treasurer, Company Secretary
- Craig Shore
- Chief Operating Officer
- Andrea Tommasoli
- Vice President - Finance, Human Resources
- Amir Kohen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $63.5M |
|---|---|
Revenue (TTM) | $6.6M |
Shares Outstanding | 25.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.94 |
EPS | $-0.74 |
Book Value | $1.81 |
P/E Ratio | -3.3x |
Price/Sales (TTM) | 9.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -412.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
